Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Radio waves fight SVT

¹St. Luke's Hospital, Bethlehem, PA, USA.

|August 4, 1998

Summary

This summary is machine-generated.

This novel treatment offers an alternative to medication for specific recurrent supraventricular tachycardia cases. Patient care guidelines are provided for those opting for this therapeutic approach.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pacemakers: keeping the beat today.

RN·2000

Same author

We turned med/surg staff into telemetry experts.

RN·1992

See all related articles

Area of Science:

Cardiology
Electrophysiology

Background:

Recurrent supraventricular tachycardia (SVT) poses a significant clinical challenge.
Medication management is the current standard first-line therapy for SVT.

Observation:

A specific non-pharmacological treatment demonstrates efficacy in managing certain SVT types.
Patient selection is crucial for successful implementation of this alternative therapy.

Findings:

This treatment modality can serve as a viable first-line option, potentially replacing traditional medications for specific SVT presentations.
Clinical protocols for patient care are essential for this treatment approach.

Implications:

This approach may alter the therapeutic landscape for recurrent SVT.

Further research into long-term outcomes and patient adherence is warranted.

Healthcare providers need updated guidelines for managing patients undergoing this treatment.